End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
179,700.00 KRW | +0.39% |
|
+2.10% | -4.16% |
02:21am | S.Korean shares end at 3-week high on tariff optimism despite Trump's comments | RE |
08:30pm | South Korean shares rise 1% on tariff optimism despite Trump's comments | RE |
Summary: Celltrion, Inc.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Highlights: Celltrion, Inc.
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses: Celltrion, Inc.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 91.41 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings Chart: Celltrion, Inc.
ESG chart: Celltrion, Inc.
Fundamentals | Valuation | Revisions of Fundamental Estimates | Capi.($) | ||
---|---|---|---|---|---|
26.18B | |||||
48.01B | |||||
36.45B | |||||
15.76B | |||||
15.43B | |||||
11.05B | |||||
10.99B | |||||
8.66B | |||||
Average | 21.57B | ||||
Weighted average by Cap. |
Financials
Valuation
Revisions
Consensus
Business Predictability
ESG
Technical analysis
- Stock Market
- Equities
- A068270 Stock
- Ratings Celltrion, Inc.